1.21. Analysis.
Comparison 1 RISPERIDONE vs TYPICAL NEUROLEPTIC MEDICATION, Outcome 21 Acceptability of treatment: 1a. Leaving study early ‐ adverse effect.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.